Medical Oncology — Clinical Documentation
Patient: 48-Year-Old Female • Metastatic Colorectal Adenocarcinoma • ECOG Performance Status: 1
Phase 1b Cohort A Consideration
⚖ Clinical Assessment Conclusion
Patient is potentially eligible for MBRC-101 but cannot be confirmed as eligible yet — key criteria remain missing or borderline. No obvious permanent contraindications identified in the information provided.
Age & Sex
48-Year-Old Female
Primary Diagnosis
Metastatic Colorectal Adenocarcinoma
ECOG Performance Status
1 — Ambulatory
Referral Purpose
Clinical Trial Eligibility Evaluation
Prior Systemic Lines
Two Lines Completed
Recent Radiotherapy
15 Days Ago
Evaluation for clinical trial eligibility following progression after two prior lines of systemic therapy. The patient is presenting for consideration of enrollment in the MBRC-101 clinical trial (Phase 1b, Cohort A).
Diagnosed with Colorectal Adenocarcinoma, now with metastatic disease.
Completed two prior lines of systemic therapy — full details to be attached in oncology summary.
Received radiotherapy 15 days ago; site and dose per radiation oncology report.
Now presenting for evaluation for enrollment in the MBRC-101 clinical trial.
Hypertension — well controlled on medical therapy.
Type 2 Diabetes Mellitus — medically managed and controlled.
No history of CVA, PAD, PE, AMI, or prior surgery documented.
Antihypertensive therapy (specific agent and dose to be listed per medication reconciliation).
Antidiabetic therapy (specific agent and dose to be listed per medication reconciliation).
Other medications per complete medication reconciliation record.
This document is a clinical oncology note intended for authorized medical personnel only. Confidential.